Show simple item record

dc.contributor.authorSalman, S.
dc.contributor.authorPage-Sharp, Madhu
dc.contributor.authorBatty, Kevin
dc.contributor.authorKose, K.
dc.contributor.authorGriffin, S.
dc.contributor.authorSiba, P.
dc.contributor.authorIlett, K.
dc.contributor.authorMueller, I.
dc.contributor.authorDavis, T.
dc.date.accessioned2017-01-30T13:54:26Z
dc.date.available2017-01-30T13:54:26Z
dc.date.created2012-05-22T20:00:38Z
dc.date.issued2012
dc.identifier.citationSalman, Sam and Page-Sharp, Madhu and Batty, Kevin T. and Kose, Kaye and Griffin, Susan and Siba, Peter M. and Ilett, Kenneth F. and Mueller, Ivo and Davis, Timothy E. 2012. Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria. Antimicrobial Agents and Chemotherapy. 56 (6): pp. 3288-3297.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/36228
dc.identifier.doi10.1128/AAC.06232-11
dc.description.abstract

Pharmacokinetic differences between piperaquine (PQ) base and PQ tetraphosphate were investigated in 34 Papua New Guinean children aged 5 to 10 years treated for uncomplicated malaria with artemisinin-PQ (ART-PQ) base or dihydroartemisinin-PQ (DHA-PQ) tetraphosphate. Twelve children received ART-PQ base (two daily doses of 3 mg of ART and 18 mg of PQ base as granules/kg of body weight) as recommended by the manufacturer, with regular clinical assessment and blood sampling over 56 days. PQ concentrations in plasma samples collected from 22 children of similar ages with malaria in a previously published pharmacokinetic study of DHA-PQ tetraphosphate (three daily doses of 2.5 mg of ART and 20 mg of PQ tetraphosphate as tablets/kg of body weight) were available for comparison. The disposition of ART was also assessed in the 12 children who received ART-PQ base. Plasma PQ was assayed by high-performance liquid chromatography with UV detection, and ART was assayed using liquid chromatography-mass spectrometry.Multicompartment pharmacokinetic models for PQ and ART were developed using a population-based approach. ART-PQ base was well tolerated, and initial fever abatement and parasite clearance were prompt. There were no differences between the two treatments in the values for the PQ area under the concentration-time curve from time zero to infinity (AUC0–∞), with medians of 49,451 (n = 12) and 44,556 (n = 22) μg • h/liter for ART-PQ base and DHA-PQ tetraphosphate, respectively. Recurrent parasitemia was associated with lower PQ exposure. Using a two-compartment ART model, the median AUC0–∞ was 1,652 μg • h/liter. There was evidence of autoinduction of ART metabolism (relative bioavailability for the second dose, 0.27). These and previously published data suggest that a 3-day ART-PQ base regimen should be further evaluated, in line with World Health Organization recommendations for all artemisinin combination therapies.

dc.publisherAmerican Society for Microbiology
dc.titlePharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria
dc.typeJournal Article
dcterms.source.volume56
dcterms.source.number6
dcterms.source.startPage3288
dcterms.source.endPage3297
dcterms.source.issn0066-4804
dcterms.source.titleAntimicrobial Agents and Chemotherapy
curtin.departmentSchool of Pharmacy
curtin.accessStatusOpen access via publisher


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record